Evolut™ FX+ System for transcatheter aortic valve implantation (TAVI)

The Evolut™ FX+ transcatheter aortic valve system is designed with specific features intended to enable lifetime management solutions such as coronary access.

Download specifications

Evolut™ FX+ TAV with a green highlighted area in the center

Alert Indications, Safety, and Warnings

Overview

Explore the Evolut™ FX+ system.

Built on the original CoreValve^TM platform, the Evolut™ FX+ valve is engineered with specific design elements to enable coronary access and promote sustained valve performance over time.^1,2

Performance as compared to Evolut™ PRO+ and FX system in bench testing. Bench testing may not be indicative of clinical performance.

Product details

Built for durability

Designed to maintain the same radial force at the inflow and structural strength at the outflow as the Evolut™ FX valve.¹

Designed for access

Designed with three windows that are 4 times larger to enable lifetime management solutions such as coronary access.²

Performance as compared to Evolut™ PRO+ and FX system in bench testing. Bench testing may not be indicative of clinical performance.

Blue outline of Evolut™ FX+ TAV with a green highlighted area in the center on navy blue circle background

Manuals and technical guides

Access instructions for use and other technical manuals in the Medtronic Manual Library. Search by the product name (e.g., Evolut™) or model number.

Resources

Find details on the Evolut™ FX+ system

pdf Evolut™ FX+ barcode and ordering information (.pdf)

813KB

pdf Evolut™ FX+ system product specifications (.pdf)

1.4MB

Education and resources

Find more details TAVI information, educational resources, and tools.

Visit Medtronic Academy

Contact us

*Indicates Required Field

Please select at least one option below:*

I would like to be contacted by a Medtronic representative

I would like to receive surveys from Medtronic regarding my customer experience

Your information will be processed and protected in accordance with our privacy statement

Selecting “no” to marketing emails above will not affect your other email selections, and a Medtronic representative will still reach out via email, if selected. Your personal data will used to manage your relationship with Medtronic, and, if you consent, to provide you with relevant email updates based on your user preferences. You can opt-out of receiving such emails at any time by clicking the unsubscribe link in the relevant email. Medtronic may use pixels and other technologies in emails to gather statistics around email opening and clicks, to help us improve our communications and to provide you with relevant content. For more information, see the Medtronic privacy notice.

You can always change your preferences or update your personal details by visiting the Preference center.

See the Preference center

1. Based on Evolut™ FX+ Test Reports: D01073856, D01095344, D01084996. Medtronic data on file. Performance as compared to Evolut™ PRO+ and FX system in bench testing. Bench testing may not be indicative of clinical performance.

2. Based on Evolut™ FX+ Test Report: DO1106198 Rev. A. Medtronic computational data model on file compared to the Evolut™ platform. Bench top computational model may not be indicative of clinical performance.